Precision Medicine

Every three minutes somewhere in the world, a person with type 1 diabetes calculates a dose of insulin and still lives with the nagging reality that even perfect math will not reproduce the split-second precision of native β-cells. Clinicians point to the autoimmune destruction that erased those

Jan Kaiserle sits down with Ivan Kairatov, a biopharma expert deeply versed in molecular therapeutics and translational research, to discuss a new approach to overcoming treatment resistance in neuroblastoma. Drawing on work published in Science Advances in 2025, Kairatov explains how a failed

In a world where neurological disorders affect millions globally, the urgency for faster, more accurate diagnoses has never been greater, with conditions like stroke and epilepsy often requiring split-second decisions to save lives or prevent irreversible damage. Artificial Intelligence (AI) has

In the realm of chronic disease management, type 2 diabetes stands as a formidable challenge, impacting millions globally and demanding innovative strategies to keep blood glucose levels in check. Among the arsenal of treatments, dipeptidyl peptidase-4 (DPP-4) inhibitors have emerged as a vital

Imagine a scenario where a patient, battling cancer that has spread to the brain, undergoes complex treatments like radiation or chemotherapy, only to face uncertainty when follow-up scans can’t clearly show whether the tumor is growing or if the changes are just treatment side effects. This

In the bustling heart of Shanghai, where innovation meets opportunity, the China International Import Expo (CIIE) stands as a beacon for global companies to showcase transformative advancements, and this year, Illumina, a titan in life sciences, has taken center stage with its groundbreaking